These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9669415)

  • 1. Procedure guideline for tumor imaging using fluorine-18-FDG. Society of Nuclear Medicine.
    Schelbert HR; Hoh CK; Royal HD; Brown M; Dahlbom MN; Dehdashti F; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1302-5. PubMed ID: 9669415
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncological applications of FDG PET imaging.
    Delbeke D
    J Nucl Med; 1999 Oct; 40(10):1706-15. PubMed ID: 10520713
    [No Abstract]   [Full Text] [Related]  

  • 3. [New functional imaging technique "positron emission tomography"].
    Tamaki N
    Hokkaido Igaku Zasshi; 1998 Mar; 73(2):101-4. PubMed ID: 9612703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond FDG: Many Molecular Imaging Agents Are in Development.
    Brower V
    J Natl Cancer Inst; 2011 Jan; 103(1):13-5. PubMed ID: 21169540
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular nuclear medicine: the best kept secret in medicine.
    Wagner HN
    J Nucl Med; 1997 Aug; 38(8):15N-17N, 36N, 38N passim. PubMed ID: 9255143
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron-emitting radiopharmaceuticals: how safe are they?
    Silberstein EB
    Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography scanning: a primer.
    Walker RC; Weiss DW; Purnell GL; Forte KF
    J Ark Med Soc; 2002 Oct; 99(4):119-21. PubMed ID: 12362654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 11. On FDG PET metabolic imaging to assess myocardial viability.
    Brunken RC; Go RT; MacIntyre WJ
    J Nucl Med; 2000 Apr; 41(4):25N. PubMed ID: 10768553
    [No Abstract]   [Full Text] [Related]  

  • 12. F-18 FDG PET scan of a metastatic pineoblastoma.
    Bakheet SM; Hassounah M; Al-Watban J; Homsi M; Powe J; Larsson S
    Clin Nucl Med; 1999 Mar; 24(3):198-9. PubMed ID: 10069738
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.
    Cook GJ; Houston S; Barrington SF; Fogelman I
    J Nucl Med; 1998 Jan; 39(1):99-103. PubMed ID: 9443745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
    Kapucu LO; Meltzer CC; Townsend DW; Keenan RJ; Luketich JD
    J Nucl Med; 1998 Jul; 39(7):1267-9. PubMed ID: 9669408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in oncology: the most sophisticated imaging technology.
    Lacić M; Maisey MN; Kusić Z
    Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric body applications of FDG PET.
    O'Hara SM; Donnelly LF; Coleman RE
    AJR Am J Roentgenol; 1999 Apr; 172(4):1019-24. PubMed ID: 10587139
    [No Abstract]   [Full Text] [Related]  

  • 18. FDG imaging of spinal cord primitive neuroectodermal tumor.
    Meltzer CC; Townsend DW; Kottapally S; Jadali F
    J Nucl Med; 1998 Jul; 39(7):1207-9. PubMed ID: 9669395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion detectability and quantitative recovery with FDG-PET.
    Links JM
    Eur J Nucl Med; 1999 Jun; 26(6):681-2. PubMed ID: 10428608
    [No Abstract]   [Full Text] [Related]  

  • 20. PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
    Schraml FV; Driver DR; Randolph T; Silverman ED
    J Nucl Med Technol; 1997 Dec; 25(4):272-4. PubMed ID: 9438929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.